Helicobacter pylori: The situation of pretherapeutical resistance rates in Germany [Ruhr area];Helicobacter pylori: Pratherapeutische Resistenzlage in Deutschland (Ruhrgebiet)

Zeitschrift fur Gastroenterologie

Volumn 35, Issue 3, 1997, Pages 165-169

  Tillenburg, Birgit ^a,b   Siehoff, S ^a   Becker, T ^a   Peitz, U ^a   Borsch G ^a   Labenz, J ^a  

^a ELISABETH KRANKENHAUS ESSEN   (Germany)

^b Medizinische Klinik Gastroenterologie Hämatologie Onkologie   (Germany)

Author keywords

antimicrobial drug resistance; clarithromycin; Helicobacter pylori; metronidazole

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; GERMANY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; STOMACH BIOPSY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, MULTIPLE; FEMALE; GASTRITIS; GERMANY; HELICOBACTER INFECTIONS; HUMANS; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; TETRACYCLINE;

EID: 0031086017     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Labenz J, Börsch G. Therapie der Helicobacter-pylori-Infektion. Dtsch med Wschr 1994; 119: 669-72
2. NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-9
3. Soll AH. Consensus Statement. Medical treatment of peptic ulcer disease. JAMA 1996; 275: 622-9
4. Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroeuterol 1996; 31 (suppl. 215): 48-51
5. Bayerdörffer E, Morgner A, Neubauer A et al. Regression of primary gastric MALT lymphoma after cure of Helicobacter pylori infection: A two-year follow-up report of the German MALT lymphoma trial. Gastroenterology 1996; 110: A490
6. Labenz J, O'Morain C. Eradication. Curr Opin Gastroenterol 1995; 11 (suppl. 1): 47-51
7. Mégraud F. H. pylori resistance to antibiotics. In: Hunt RH, Tytgat GNJ (eds.). Helicobacter pylori. Basic mechanisms to clinical cure. Dordrecht, Kluwer Academic Publishers 1994, 570-83
8. Midolo PD, Lambert JR, Turnbridge J. Metronidazole resistance: A predictor of failure of Helicobacter pylori eradication by triple therapy. J Gastroenterol Hepatol 1996; 11: 290-2
9. Noach LA, Langenberg WL, Bertola MA, Dankert J, Tytgat GNJ. Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis 1994; 26: 321-7
10. Penston JG. Helicobacter pylori eradication - understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994; 8: 369-89
11. Tytgat GNJ. Review article. Treatments that impact favourable upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359-68
12. Glupczynski Y, Labbe M, Hansen W, Croekaert F, Yourassowsky E. Evaluation of the E-test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol 1991; 29: 2072-5
13. Glupczynski Y. Susceptibility of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1992; 11: 777-81
14. Von Recklinghausen G, Ansorg R. Metronidazole susceptibility testing of Helicobacter pylori with the PDM Epsilometer Test (E-test). Zbl Bakt 1995; 282: 83-5
15. Glupczynski Y, Goutier S, Van den Borre C, Butzler JP, Burette A. Surveillance of Helicobacter pylori resistance to antimicrobial agents in Belgium from 1989 to 1994. Gut 1995; 37 (suppl. 1): A56
16. Reddy R, Osato M, Gutiérrez O, Kim JG, Graham DY. Metronidazole resistance is high in Korea and Colombia and appears to be rapidly increasing in the U. S. Gastroenterology 1996; 110: A238
17. Midolo PD, Korman MG, Turnidge JD, Lambert JR. Helicobacter pylori resistance to tetracycline. Lancet 1996; 347: 1194-5
18. Cederbrant G, Kahlmeter G, Schalén C, Kamme C. Additive effect of clarithromycin with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omperazole against Helicobacter pylori. J Antimicrob Chemother 1994; 34: 1025-9
19. Chang K, Wyle F, Skankey J et al.Clarithromycin achieves highest tissue concentrations among anti- Helicobacter pylori antibiotics. Gastroenterology 1993; 104: A680
20. Gustavson LE, Kaiser JF, Edmonds AL et al. Effect of omeprazole on concentration of clarithromycin in plasma and gastric tissue at steady state. Antimicrob Agents Chemother 1995; 39: 2078-87
21. Logan RPH, Gummett PA, Schaufelberger HD et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994; 35: 323-6
22. Cayla R, Zerbib F, Mégraud F, Lamouliatte H. Clarithromycin resistance of Helicobacter pylori strains before and after treatment: A key factor of treatment failures. Gastroenterology 1995; 108: A 68
23. Versalovic J, Kibler K, Small S et al. Molecular basis of clarithromycin resistance in Helicobacter pylori. Gastroenterology 1995; 108: A251
24. Xia HX, Keane CT, O'Morain CA. Prevalence and stability of clarithromycin resistance in Helicobacter pylori: Clinical implications. Am J Gastroenterol 1994; 89: 1391
25. De Boer W, Driessen W, Jansz A, Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 817-20
26. Bazzoli F, Zagari RM, Fossi S et al. Efficacy and tolerability of a short-term, low-dose triple therapy for eradication of Helicobacter pylori. Gastroenterology 1993; 104: A140
27. Goddard A, Logan R. One-week low-dose triple therapy: New standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 7 1995, 7: 1-3
28. Labenz J, Bl̈rsch G. Towards an optimal treatment of Helicobacter pylori-positive peptic ulcers. Am J Gastroenterol 1995; 90: 692-4
29. Lind T, Veldhuyzen van Zanten SJO, Unge P et al. The MACH 1 study: Optimal one-week treatment for H. pylori defined? Gut 1995; 37 (suppl. 1): A4
30. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7: 835-40
31. Buckley M, Keating S, Xia H et al. Omeprazole plus one or two antibiotics to eradicate H. pylori. Gastroenterology 1995; 108: A63
32. Peitz U, Nusch A, Tillenburg B et al. Frequent metronidazole resistance without significant impact on the high cure rate of Helicobacter pylori (HP) by triple therapy with omeprazole (OME), Metronidazole (MET), and clarithromycin (CLA). Gastroenterology 1996; 110: A226
33. Cederbrant G, Kahlmeter G, Ljungh A. Proposed mechanisms for metronidazole resistance in Helicobacter pylori. J Animicrob Chemother 1992; 29 (2): 115-20